Next week, Sarah Skerratt, Chief Research Officer at Isomorphic Labs, will be in Washington D.C. for Revolution 2026.
She’ll join a panel to talk about how AI is being used in drug discovery today, and how our drug design engine is speeding up the path from early research to potential new medicines.
Head to the comments for the agenda.